In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro talks about...
Category - Pharma Leaders
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of...
FDA Approves Bavarian Nordic’s Chikungunya Vaccine Vimkunya
Global Launch Strategies in the Current Political Climate
Pharma Pulse 2/19/25: The Impact of Telehealth Reimbursement Policies, Cuts to Indirect Research Costs To Impact T1D & more
Epitopea Strikes Research Collaboration with Merck, Appoints Klaus Edvardsen as Chief Medical Officer
Former Health Agency Heads React to Federal Layoffs at NIH, CDC, and FDA
Applyo Jena Closes Successful Series A Funding Round
How Collaborations Help Abpro’s Success